Academic Journal

FP03.03 ECOG PS of 0-1 and Very High PD-L1 Expression ≥90% Are Associated With Clinical Benefit From First-Line Chemo-Immunotherapy in Advanced NSCLC

التفاصيل البيبلوغرافية
العنوان: FP03.03 ECOG PS of 0-1 and Very High PD-L1 Expression ≥90% Are Associated With Clinical Benefit From First-Line Chemo-Immunotherapy in Advanced NSCLC
المؤلفون: Ricciuti, B., Alessi, J., Alden, S., Recondo, G., Nishino, M., Sholl, L., Awad, M.
المصدر: Journal of Thoracic Oncology ; volume 16, issue 10, page S948-S949 ; ISSN 1556-0864
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jtho.2021.08.213
الاتاحة: http://dx.doi.org/10.1016/j.jtho.2021.08.213
https://api.elsevier.com/content/article/PII:S1556086421026368?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1556086421026368?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.7CA129AA
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.jtho.2021.08.213